Literature DB >> 19129507

High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease.

D E Vaillancourt1, M B Spraker, J Prodoehl, I Abraham, D M Corcos, X J Zhou, C L Comella, D M Little.   

Abstract

BACKGROUND: In the midbrain of patients with Parkinson disease (PD), there is a selective loss of dopaminergic neurons in the ventrolateral and caudal substantia nigra (SN). In a mouse model of PD, investigators have administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and found that measures derived using diffusion tensor imaging (DTI) were correlated with the number of dopamine neurons lost following intoxication.
METHODS: Twenty-eight subjects (14 with early stage, untreated PD and 14 age- and gender-matched controls) were studied with a high-resolution DTI protocol at 3 Tesla using an eight-channel phase array coil and parallel imaging to study specific segments of degeneration in the SN. Regions of interest were drawn in the rostral, middle, and caudal SN by two blinded and independent raters.
RESULTS: Fractional anisotropy (FA) was reduced in the SN of subjects with PD compared with controls (p < 0.001). Post hoc analysis identified that reduced FA for patients with PD was greater in the caudal compared with the rostral region of interest (p < 0.00001). A receiver operator characteristic analysis in the caudal SN revealed that sensitivity and specificity were 100% for distinguishing patients with PD from healthy subjects. Findings were consistent across both raters.
CONCLUSIONS: These findings provide evidence that high resolution diffusion tensor imaging in the substantia nigra distinguishes early stage, de novo patients with Parkinson disease (PD) from healthy individuals on a patient by patient basis and has the potential to serve as a noninvasive early biomarker for PD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19129507      PMCID: PMC2677508          DOI: 10.1212/01.wnl.0000340982.01727.6e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  26 in total

1.  Non-invasive assessment of axonal fiber connectivity in the human brain via diffusion tensor MRI.

Authors:  D K Jones; A Simmons; S C Williams; M A Horsfield
Journal:  Magn Reson Med       Date:  1999-07       Impact factor: 4.668

2.  Retrospective measurement of the diffusion tensor eigenvalues from diffusion anisotropy and mean diffusivity in DTI.

Authors:  Khader M Hasan; Ponnada A Narayana
Journal:  Magn Reson Med       Date:  2006-07       Impact factor: 4.668

Review 3.  The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.

Authors:  Mojgan Hodaie; Joseph S Neimat; Andres M Lozano
Journal:  Neurosurgery       Date:  2007-01       Impact factor: 4.654

Review 4.  Principles of diffusion tensor imaging and its applications to basic neuroscience research.

Authors:  Susumu Mori; Jiangyang Zhang
Journal:  Neuron       Date:  2006-09-07       Impact factor: 17.173

5.  Imaging the living human brain: magnetic resonance imaging and positron emission tomography.

Authors:  N D Volkow; B Rosen; L Farde
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

6.  Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI.

Authors:  P J Basser; C Pierpaoli
Journal:  J Magn Reson B       Date:  1996-06

Review 7.  The role of radiotracer imaging in Parkinson disease.

Authors:  B Ravina; D Eidelberg; J E Ahlskog; R L Albin; D J Brooks; M Carbon; V Dhawan; A Feigin; S Fahn; M Guttman; K Gwinn-Hardy; H McFarland; R Innis; R G Katz; K Kieburtz; S J Kish; N Lange; J W Langston; K Marek; L Morin; C Moy; D Murphy; W H Oertel; G Oliver; Y Palesch; W Powers; J Seibyl; K D Sethi; C W Shults; P Sheehy; A J Stoessl; R Holloway
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

8.  Clinical and [18F] dopa PET findings in early Parkinson's disease.

Authors:  P K Morrish; G V Sawle; D J Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-12       Impact factor: 10.154

9.  Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson's disease.

Authors:  Michael D Boska; Khader M Hasan; Danette Kibuule; Rebecca Banerjee; Erin McIntyre; Jay A Nelson; Theresa Hahn; Howard E Gendelman; R Lee Mosley
Journal:  Neurobiol Dis       Date:  2007-03-06       Impact factor: 5.996

10.  Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy.

Authors:  D C Paviour; S L Price; J M Stevens; A J Lees; N C Fox
Journal:  Neurology       Date:  2005-02-22       Impact factor: 9.910

View more
  163 in total

Review 1.  Neuroimaging in Parkinson's disease.

Authors:  A Jon Stoessl
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Idiopathic REM sleep behavior disorder and Parkinson's disease--two sides of one coin?

Authors:  Niels K Focke; Claudia Trenkwalder
Journal:  Sleep       Date:  2010-06       Impact factor: 5.849

Review 3.  Neuroimaging and cognition in Parkinson's disease dementia.

Authors:  Lisa C Silbert; Jeffrey Kaye
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

4.  Blood oxygenation level-dependent activation in basal ganglia nuclei relates to specific symptoms in de novo Parkinson's disease.

Authors:  Janey Prodoehl; Mathew Spraker; Daniel Corcos; Cynthia Comella; David Vaillancourt
Journal:  Mov Disord       Date:  2010-10-15       Impact factor: 10.338

5.  Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease.

Authors:  Tyler M Rolheiser; Heather G Fulton; Kimberley P Good; John D Fisk; J Roger McKelvey; Christophe Scherfler; Naeem M Khan; Ronald A Leslie; Harold A Robertson
Journal:  J Neurol       Date:  2011-02-03       Impact factor: 4.849

6.  Cognitive status correlates with white matter alteration in Parkinson's disease.

Authors:  Takaaki Hattori; Satoshi Orimo; Shigeki Aoki; Kenji Ito; Osamu Abe; Atsushi Amano; Ryo Sato; Kasumi Sakai; Hidehiro Mizusawa
Journal:  Hum Brain Mapp       Date:  2011-04-14       Impact factor: 5.038

7.  Free water improves detection of changes in the substantia nigra in parkinsonism: A multisite study.

Authors:  Edward Ofori; Florian Krismer; Roxana G Burciu; Ofer Pasternak; Johanna L McCracken; Mechelle M Lewis; Guangwei Du; Nikolaus R McFarland; Michael S Okun; Werner Poewe; Christoph Mueller; Elke R Gizewski; Michael Schocke; Christian Kremser; Hong Li; Xuemei Huang; Klaus Seppi; David E Vaillancourt
Journal:  Mov Disord       Date:  2017-07-17       Impact factor: 10.338

8.  Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes.

Authors:  Mechelle M Lewis; Guangwei Du; Jennifer Baccon; Amanda M Snyder; Ben Murie; Felicia Cooper; Christy Stetter; Lan Kong; Christopher Sica; Richard B Mailman; James R Connor; Xuemei Huang
Journal:  Mov Disord       Date:  2018-05-14       Impact factor: 10.338

Review 9.  The evolving role of diffusion magnetic resonance imaging in movement disorders.

Authors:  Christopher W Hess; Edward Ofori; Umer Akbar; Michael S Okun; David E Vaillancourt
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

10.  iPGA: incremental principal geodesic analysis with applications to movement disorder classification.

Authors:  Hesamoddin Salehian; David Vaillancourt; Baba C Vemuri
Journal:  Med Image Comput Comput Assist Interv       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.